10/07/2019 |
IRLAB Theraoeutics AB |
VEDICUS AB |
Styrelseledamot/suppleant |
Yes |
Exchange increase |
IRLAB Therapeutics Serie A |
Share |
SE0012675361 |
10/07/2019 |
19,478 |
Quantity |
92.18 |
SEK |
Revised |
Notification
|
10/07/2019 |
IRLAB Therapeutics AB |
Nicholas Waters |
VD |
|
Exchange decrease |
IRLAB Therapeutics AB serie B |
Share |
SE0012675379 |
10/07/2019 |
31,299 |
Quantity |
92.18 |
SEK |
|
Notification
|
10/07/2019 |
IRLAB Therapeutics AB |
Nicholas Waters |
VD |
|
Exchange increase |
IRLAB Therapeutics AB serie A |
Share |
SE0012675361 |
10/07/2019 |
31,299 |
Quantity |
92.18 |
SEK |
|
Notification
|
10/07/2019 |
IRLAB Therapeutics AB |
Susanna Holm Waters |
Director of Biology and Biostatistics |
|
Exchange decrease |
IRLAB Therapeutics AB serie B |
Share |
SE0012675379 |
10/07/2019 |
31,299 |
Quantity |
92.18 |
SEK |
|
Notification
|
10/07/2019 |
IRLAB Therapeutics AB |
Susanna Holm Waters |
Director of Biology and Biostatistics |
|
Exchange increase |
IRLAB Therapeutics AB serie A |
Share |
SE0012675361 |
10/07/2019 |
31,299 |
Quantity |
92.18 |
SEK |
|
Notification
|
10/07/2019 |
IRLAB Therapeutics AB |
Joakim Tedroff |
CMO |
|
Exchange decrease |
IRLAB Therapeutics AB serie B |
Share |
SE0012675379 |
10/07/2019 |
31,299 |
Quantity |
92.18 |
SEK |
|
Notification
|
10/07/2019 |
IRLAB Therapeutics AB |
Joakim Tedroff |
CMO |
|
Exchange increase |
IRLAB Therapeutics AB serie A |
Share |
SE0012675361 |
10/07/2019 |
31,299 |
Quantity |
92.18 |
SEK |
|
Notification
|
10/07/2019 |
IRLAB Therapeutics AB |
Cecilia Tivert Stenberg |
Ekonomi/finanschef |
Yes |
Exchange decrease |
IRLAB Therapeutics AB, Serie B |
Share |
SE0012675379 |
10/07/2019 |
31,299 |
Quantity |
92.18 |
SEK |
History |
Notification
|
10/07/2019 |
IRLAB Therapeutics AB |
Cecilia Tivert Stenberg |
Ekonomi/finanschef |
Yes |
Exchange increase |
IRLAB Therapeutics AB, Serie A |
Share |
SE0012675361 |
10/07/2019 |
31,299 |
Quantity |
92.18 |
SEK |
History |
Notification
|
10/07/2019 |
IRLAB Therapeutics AB |
Cecilia Tivert Stenberg |
Ekonomi/finanschef |
Yes |
Exchange decrease |
IRLAB Therapeutics AB, Serie B |
Share |
SE0012675379 |
10/07/2019 |
31,299 |
Quantity |
92.18 |
SEK |
Revised |
Notification
|